Canada markets closed

Syngen Biotech Co.,Ltd. (8279.TWO)

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD
Add to watchlist
155.00-3.00 (-1.90%)
At close: 01:30PM CST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
261,659
274,827
321,236
237,770
215,550
-
Depreciation & amortization
102,591
99,474
86,500
81,397
76,665
-
Stock based compensation
-
-
-
-
0
8,648
Change in working capital
21,906
72,985
-158,110
-3,015
-68,677
-
Inventory
32,318
1,984
-98,109
-41,330
-51,500
-
Other working capital
260,711
321,329
-307,228
274,829
-52,554
-
Other non-cash items
13,589
17,980
13,923
6,400
5,448
-
Net cash provided by operating activites
353,975
415,130
277,484
336,498
220,200
-
Cash flows from investing activities
Investments in property, plant and equipment
-93,264
-93,801
-584,712
-61,669
-272,754
-
Acquisitions, net
-
-
0
-273,840
0
-
Other investing activites
-16
124
-334
-1,034
693
-
Net cash used for investing activites
-93,280
-93,677
-585,046
-336,075
-272,061
-
Net change in cash
95,846
120,838
-68,748
-108,616
-95,976
-
Cash at beginning of period
274,432
246,053
314,801
423,417
519,393
-
Cash at end of period
370,256
366,891
246,053
314,801
423,417
-
Free Cash Flow
Operating Cash Flow
353,975
415,130
277,484
336,498
220,200
-
Capital Expenditure
-93,264
-93,801
-584,712
-61,669
-272,754
-
Free Cash Flow
260,711
321,329
-307,228
274,829
-52,554
-